Oxford StemTech is advancing drug discovery and precision medicine through human stem cell technologies. An Oxford University spinout, Oxford StemTech develops and delivers advanced human induced pluripotent stem cell (iPSC) models and assay platforms to accelerate disease research, drug target discovery, and therapeutic development. Our capabilities span the entire iPSC workflow, from scalable reprogramming and genome engineering to directed differentiation, complex 3D organoids and assembloids, and functional phenotyping. We specialise in generating disease-relevant human cellular models, including neurons, microglia, macrophages and oligodendrocytes, supported by advanced technologies such as multi-electrode array (MEA) electrophysiology, high-content imaging and molecular profiling. By combining patient-specific stem cell models with scalable functional assays, we enable researchers and pharmaceutical companies to investigate disease mechanisms, identify and validate drug targets and evaluate therapeutic efficacy. Our ambition is to bridge the gap between conventional preclinical models and human biology, enabling drug discovery across genetically diverse patient populations and supporting the development of more effective, personalised medicines. From patient-derived cells to actionable insights for drug discovery and precision medicine.
| Website | https://www.oxfordstemtech.com |
| Employees | 8 (6 on RocketReach) |
| Founded | 2020 |
| Phone | +44 1869 238035 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Stem Cell Research, Drug Discovery, Pharmaceutical Research, Pluripotent Stem Cells, Preclinical Research, Regenerative Medicine, Cell Culture, Cellular Reprogramming, Disease Modeling, Cell Therapy, Therapeutic Applications, Biomanufacturing, Biotechnology, Clinical Trials, Life Sciences, Research Tools, Scientific Research |
| Competitors | Thermo Fisher Scientific, Illumina, Agilent Technologies, Miltenyi Biotec, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Fisher Scientific, Merck Group, GE HealthCare +36 more (view full list) |
Looking for a particular Oxford StemTech employee's phone or email?
Galbha Duggal is the Chief Scientific Officer, Co-Founder of Oxford StemTech.
6 people are employed at Oxford StemTech.